Establishment LabsvsJohnson & Johnson

ESTA and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

ESTA

Establishment Labs Holdings Inc.

$69.14

Value $2.0B

-0.68%
ESTA's page

Establishment Labs (ESTA) has a market value of $2.0B and Johnson & Johnson (JNJ) $652B. Over the last year, with dividends, ESTA moved +3.4% and JNJ +36.6%. Dividend yield: ESTA none, JNJ 1.95%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ESTA$2.0B

    JNJ$652B

    JNJ is 322 times ESTA

  • Revenue, 12 months

    ESTA$264M

    JNJ$99.3B

    JNJ is 376 times ESTA

  • Net income, 12 months

    ESTA-$38M

    JNJ$16.1B

  • Operating margin

    ESTA-6.6%

    JNJ–

  • ROIC

    ESTA-5.0%

    JNJ12.4%

    17.4 points apart

  • P/E

    ESTA–

    JNJ40.5

  • Dividend yield

    ESTA0.0%

    JNJ2.0%

    2.0 points apart

  • 5-year return

    ESTA+7.2%

    JNJ+90.9%

    83.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ESTA+7.2%

JNJ+90.9%

5010015020020222023202420252026
Returns by period
PeriodESTAWith dividendsJNJWith dividends
1 year since November 19, 2025+3.4%Price +3.4%+36.6%Price +33.6%
3 years since November 20, 2023+214.3%+46.5% a yearPrice +214.3%+94.9%+24.9% a yearPrice +80.4%
5 years since November 19, 2021+7.2%+1.4% a yearPrice +7.2%+90.9%+13.8% a yearPrice +66.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ESTAEstablishment LabsJNJJohnson & Johnson

Valuation

ESTAJNJ
Valuation
Price$69.14$270.47
Market value$2.0B$652B
Enterprise value (EV)–$679B
P/E–40.5
P/E, 5-year median–21.9
P/B130.08.0
EV/EBIT–38.3
Free cash flow yield–3.2%

Results and growth

ESTAJNJ
Results and growth
Revenue, 12 months$264M$99.3B
Net income, 12 months-$38M$16.1B
Free cash flow, 12 months-$22M$20.6B
Earnings per share, 12 months-$1.27$6.59
Revenue growth, year on year27.1%6.1%
Revenue growth a year, past+20.0%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

ESTAJNJ
Margins and returns on capital
Gross margin70.2%67.6%
Operating margin-6.6%–
Net margin-14.6%16.2%
ROIC-5.0%12.4%
ROE-209.2%19.7%

Balance sheet

ESTAJNJ
Balance sheet
Cash$76M$17.2B
Total debt–$44.7B
Net debt / EBITDA–1.1
Interest cover-0.6×18.0×

Dividends and buybacks

ESTAJNJ
Dividends and buybacks
Dividend yield–2.0%
Dividend per share, 12 months–$5.28
Dividend growth a year, past–+5.3%over 5 years
Buyback yield–0.9%
Shareholder yield–2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ESTA or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Establishment Labs or Johnson & Johnson?

By market value, Johnson & Johnson ($652B) is about 321.5 times Establishment Labs ($2.0B), at today's prices.

How did ESTA and JNJ stock do over the last 5 years?

Since November 19, 2021, ESTA's price moved +7.2% and JNJ's +66.0%. With dividends: ESTA +7.2% (+1.4% a year), JNJ +90.9% (+13.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, ESTA or JNJ?

The dividend yield at today's price is none for Establishment Labs and 1.95% for Johnson & Johnson. Over the last twelve months they paid – and $5.28 per share.

Which has the higher profit margins, Establishment Labs or Johnson & Johnson?

Over the last twelve months, the net margin was -14.6% for Establishment Labs and 16.2% for Johnson & Johnson, and the operating margin -6.6% and –. Revenue was $264M and $99.3B.

Which is the better investment, Establishment Labs or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.